Study of the Combination of Bortezomib and Dexamethasone Followed by HSCT in AL.
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Melphalan
- Indications Amyloidosis
- Focus Therapeutic Use
- 05 Apr 2017 Status changed from recruiting to completed.
- 10 Aug 2016 Planned number of patients changed from 30 to 21.
- 10 Aug 2016 Status changed from active, no longer recruiting to recruiting.